Literature DB >> 10080232

Differences in central and peripheral responses to oxotremorine in young and aged rats.

E B Espínola1, M G Oliveira, E A Carlini.   

Abstract

Few studies have investigated the pharmacological response of agents that act on the cholinergic system from the point of view of age. The present article investigated central responses (tremor) and peripheral responses (chromodacryorrhea) subsequent to the administration of oxotremorine to young (3-6 months of age) and aged rats (24-30 months of age). The aged rats presented greater duration and intensity of tremor in three doses utilized (0.25, 0.5, and 1.0 mg/kg) compared to young rats. These two groups of animals did differ in latency for the onset of the tremor. The aged rats presented more intense chromodacryorrhea than the young rats in all utilized doses. These data are indicative that both responses--central and peripheral--are affected by aging, possibly as a result of pharmacokinetic alterations and/or alterations in functionality of the cholinergic system in aged rats.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10080232     DOI: 10.1016/s0091-3057(98)00192-0

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  4 in total

1.  The cannabinoid receptor antagonist AM251 increases paraoxon and chlorpyrifos oxon toxicity in rats.

Authors:  Jing Liu; Carey Pope
Journal:  Neurotoxicology       Date:  2014-11-20       Impact factor: 4.294

2.  Endocannabinoid signaling in neurotoxicity and neuroprotection.

Authors:  C Pope; R Mechoulam; L Parsons
Journal:  Neurotoxicology       Date:  2009-12-05       Impact factor: 4.294

3.  Comparative effects of parathion and chlorpyrifos on endocannabinoid and endocannabinoid-like lipid metabolites in rat striatum.

Authors:  Jing Liu; Loren Parsons; Carey Pope
Journal:  Neurotoxicology       Date:  2015-07-26       Impact factor: 4.294

4.  In vivo antimuscarinic actions of the third generation antihistaminergic agent, desloratadine.

Authors:  G Howell; L West; C Jenkins; B Lineberry; D Yokum; R Rockhold
Journal:  BMC Pharmacol       Date:  2005-08-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.